Laboratories Canada CAE Working Group
Revision as of 11:28, 5 July 2019 by Dimitrios.kakarelis (talk | contribs) (Created page with " = Meetings:= <!-- <div class="mw-collapsible-content Show"><div class="mw-collapsible-content Show"> </div> --> ===July 9, 2019=== {| class="wikitable" border="1" width="1...")
Meetings:
July 9, 2019
| Agenda | Materials |
| 1. Opening Remarks | [[Media: | ]] |
July 2, 2019
| Agenda | Materials |
| 1. Opening Remarks | Distributed via email: CAE Working Group Record of Discussion - March 7, 2019 |
| 2. Terms of Reference - Amendment | Terms of Reference - Amendment #1 |
| 3. Observations on Recent Investments in Collaborative Scientific Infrastructure - Update | i) Overview |
| 4. Governance Health Check - Update | i) Overview |
| 5. Debrief from Rob Wright, ADM, Science and Parliamentary Infrastructure | Laboratories Canada Deck |
| 6. Transformation Assurance Strategy | i) Overview |
| 7. Roundtable | No materials |
| 8. Closing Remarks | No materials |
March 7, 2019
| Agenda | Materials |
| 1. Opening Remarks | No materials |
| 2. Update on OCG Transformation Working Group | No materials |
| 3. Identify 5 Clusters & Key Stakeholders | 5 Clusters and Key Stakeholders |
| 4. Brainstorm on Objectives (Protocols for Committee/TOR) | Initial Draft Terms of Reference |
| 5. Planned PSPC Engagements 2019-2020 | No materials |
| 6. Roundtable | No materials |
